Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
  1. Home
  2. Publications
  3. Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy

Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy

Authors:
  • YHYingqin Hou
    Yingqin Hou
  • JZJaroslav Zak
    Jaroslav Zak
  • YSYujie Shi
    Yujie Shi
  • IPIsaraphorn Pratumchai
    Isaraphorn Pratumchai
  • BDBrandon Dinner
    Brandon Dinner
  • WWWenjian Wang
    Wenjian Wang
  • KQKe Qin
    Ke Qin
  • EWEvan W. Weber
    Evan W. Weber
  • JTJohn R. Teijaro
    John R. Teijaro
  • PWPeng Wu
    Peng Wu

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32698819
Abstract
Figure S11 Overlap of transcriptomic impact of Ezh2 deletion vs Taz treatment on CD8 T Cells.
Keywords
  • IMMUNOLOGY
  • T CELL EXHAUSTION
  • TUMOR IMMUNOLOGY ANIMAL MODELS
  • IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.